Traditionally, mammalian cells are grown in a 2-dimensional environment, such as petri dishes, but this is not without its setbacks, namely the forced polarity that cells undergo due to the nature of the culture environment.
Cells grown 3-dimensionally exhibit more physiologically relevant characteristics.
Copner Biotech’s state of the art design and manufacturing process enables 3D cell culture scaffolds to be produced based on concentric shape constructs, such as circles, providing a consistent variability of pore size (heterogenous pore size and distribution) emanating from the centre to the periphery of scaffold.
The effect is to provide clear regions of the scaffold where cells will have more favourable nutrient and oxygen exchange (periphery)and areas not so (centre). Such constructs better represents physiological conditions in the body providing tangible experimental advantages for research in fields studying cell microenvironments.
We are currently investigating the efficacy of an original scaffold design with Swansea University and have ongoing interest from a well known life sciences vendor.
Bioprinting is the 3D printing of biological materials, which may or may not be laden with mammalian cells. The predominant use of bioprinting is the production of tissue like structures for drug testing, with more and more large companies looking towards this technology as an alternative to animal testing.
In the long term, Copner Biotech will ultimately aim to establish a foothold in the bioprinting market. We will do this via innovative, industrial collaborations with like-minded companies already in this space, utilising our novel technology. We continue to work upon and develop our existing technologies, in the software and 3D printing hardware space, to create competitive products.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.